Terms: = Skin cancer AND EBF1, COE1, 1879, ENSG00000164330, Q9UH73, OLF1, O/E-1, EBF AND Treatment
6 results:
1. Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D).
Saw RP; Armstrong BK; Mason RS; Morton RL; Shannon KF; Spillane AJ; Stretch JR; Thompson JF
BMC Cancer; 2014 Oct; 14():780. PubMed ID: 25343963
[TBL] [Abstract] [Full Text] [Related]
2. Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009.
Jung GW; Dover DC; Salopek TG
Br J Dermatol; 2014 Jan; 170(1):136-43. PubMed ID: 24443913
[TBL] [Abstract] [Full Text] [Related]
3. Single-stage, multimodality treatment of soft-tissue sarcoma of the extremity.
Abramson DL; Orgill DP; Singer S; Gibstein LA; Pribaz JJ
Ann Plast Surg; 1997 Nov; 39(5):454-60. PubMed ID: 9374140
[TBL] [Abstract] [Full Text] [Related]
4. Risk of second malignant neoplasms among long-term survivors of testicular cancer.
Travis LB; Curtis RE; Storm H; Hall P; Holowaty E; Van Leeuwen FE; Kohler BA; Pukkala E; Lynch CF; Andersson M; Bergfeldt K; Clarke EA; Wiklund T; Stoter G; Gospodarowicz M; Sturgeon J; Fraumeni JF; Boice JD
J Natl Cancer Inst; 1997 Oct; 89(19):1429-39. PubMed ID: 9326912
[TBL] [Abstract] [Full Text] [Related]
5. Second cancers in patients with chronic lymphocytic leukemia.
Travis LB; Curtis RE; Hankey BF; Fraumeni JF
J Natl Cancer Inst; 1992 Sep; 84(18):1422-7. PubMed ID: 1512794
[TBL] [Abstract] [Full Text] [Related]
6. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease.
Henry-Amar M
Ann Oncol; 1992 Sep; 3 Suppl 4():117-28. PubMed ID: 1450072
[TBL] [Abstract] [Full Text] [Related]